Takeda Pharmaceutical Co. Ltd.Eigentümerstruktur
| Preis (2026-07-29) | 52W Hoch | 52W Tief |
| 34.94 USD | 39,2 USD | 26,33 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| - USD | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 1.596.751.439 | - | - |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Takeda Pharmaceutical Co. Ltd.
Mitarbeiter 47.029
Handelsplatz PINK
Ticker Symbol TKPHF
IPO Datum -
Adresse 1-1, Nihonbashi-Honcho 2-chome, Chuo, Japan, 103-8668
Webseite https://www.takeda.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Milano Furuta | CFO & Director |
| 2 | Dr. Andrew S. Plump M.D., Ph.D. | President of Research & Development and Representative Director |
| 3 | Ms. So-Young Kim | CEO, President & Director |
| 4 | Dr. Seigo Izumo | Chair of Management Board |
| 5 | Mr. Haruhiko Hirate | Member of Management Board |
| 6 | Mr. Salvatore Alesci M.D., Ph.D. | Member of Management Board and Head of R&D Global Science & Biomedical Policy |
| 7 | Michael Fox | Chief Operating Officer |
| 8 | Norimasa Takeda | Chief Accounting Officer & Corporate Controller |
| 9 | Mr. Iwaaki Taniguchi | Senior Vice President of Corporate Finance & Controlling Department |
| 10 | Mr. Gabriele Ricci | Chief Data & Technology Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
Für dieses Unternehmen liegen derzeit keine Daten zu institutionellen Investoren vor.